Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,583 pts at 11 international centers undergoing percutaneous coronary intervention (PCI) with DES designed to determine the frequency, timing, and correlates (clinical, angiographic and platelet reactivity) of early and late ST. In a pre-specified IVUS substudy, outcomes were examined according to IVUS vs. angiographic guidance. We herein report the 2-year clinical results. Results: Average pt age was 64.0 years, and 74.1% were male. During the index procedure, IVUS guidance was used in 3,361 (39.2%) of procedures. Pts in the IVUSguided group were more likely to present with an acute coronary syndrome and have higher platelet reactivity on clopidogrel (PRU>208), and were treated with longer and larger stents. At 2-year follow-up, definite/probable ST occurred in 22 (0.7%) pts in the IVUS-guidance group vs 71 (1.4%) pts in the angiography-guidance group (P¼0.002; Table) . In a propensity adjusted multivariable model, IVUS guidance was independently associated with a reduced 2-year rate of ST ( Conclusions: These data, drawn from the largest prospective study of IVUS-guided DES implantation to date, strongly suggest that IVUS guidance may result in improved clinical outcomes after DES, with reduced 2-year rates of ST, TLR and TVR, and death/MI.
Hospital and University Fribourg, Switzerland, Fribourg, Switzerland, 10 MedStar Washington Hosp Center, Washington, DC, 11 Cardialysis, Rotterdam, Rotterdam, 12 Universitäts-Herzzentrum Freiburg -Bad Krozingen, Bad Krozingen, Germany Background: The current study compared the novel Biotronik Osiro stent, eluting sirolimus from a biodegradable polymer PLLA, applied to the surface of a thin-strut (60 mm) Silicon-Carbide coated Cobalt-Chromium stent with the Abbot Xience PrimeÔ stent. The aim was to compare the neointimal hyperplasia, stent apposition and stent strut coverage at 9 months after procedure using IVUS and OCT imaging techniques. Methods: We performed a prospective, multicenter, randomized controlled study (RCT) in 452 subjects (63.4AE10.0 yrs) with symptomatic coronary artery disease due to de novo stenotic lesions in native coronary arteries with a reference vessel diameter ! 2.25 mm and 4.0 mm and a lesion length 26 mm. The study is registered at clinicaltrials.gov (NCT01356888). Subjects were randomly assigned (2:1) to receive the Osiro SES or the Xience PrimeÔ EES. In pre-specified cohort sizes, the enrolled subjects were invited to participate in either the IVUS (N¼66) or the OCT (N¼65) sub studies. All subjects were enrolled between July 5, 2011 -Jan 10, 2012. The IVUS endpoints were neointimal hyperplasia and stent apposition at 9 months after procedure. The OCT endpoints were neointimal hyperplasia, stent apposition and stent strut coverage at 9 months. Baseline and 9 month follow-up images were analyzed by independent and blinded core laboratories; IVUS by Medstar, US and OCT by Cardialysis, NL. Results: IVUS and OCT confirmed complete and a non-significant difference in apposition in both cohorts (OCT P¼0.624 and IVUS P¼0.325). IVUS and OCT confirmed less neointimal hyperplasia area at 9-months in the Osiro cohort (OCT P¼0.024 and IVUS P¼0.043). The Osiro cohort had a higher strut coverage and lower strut-neointima thickness at 9 months, confirmed by OCT (coverage P¼0.042 and thickness P<0.001). Conclusions: In this RCT, the Osiro SES with a biodegradable polymer showed comparable stent and strut apposition to the Xience PrimeÔ EES with a durable polymer. The Osiro had a statistically significant lower neointimal area in both the IVUS and OCT sub studies. OCT analysis of the strut level confirmed that both the neointima thickness and percent coverage was significantly better in the Osiro cohort.
TCT-70
Ability of the bioresorbable vascular scaffold to re-cap the underlying plaque. A serial optical coherence tomography study Thoraxcenter, Erasmus MC, N/A Background: The objective of this study is to examine the phenotypic changes of the superficial plaque occurring follow an Absorb bioresorbable vascular scaffold (Absorb BVS) implantation. Methods: Forty six patients (47 lesions) who underwent Absorb BVS implantation and had serial optical coherence tomographic evaluation at baseline, and at any follow-up time point (6 months, 1 year, 2 years or 3 years) were included in the current analysis. Two observers identified thin capped fibroatheromas (TCFA) in the scaffolded and native segments that were located proximally or distally to the scaffolded segment, marked the circumferential location of the TCFA and of the calcific tissues and measured the thickness of the developed neointima at follow-up. These data were used to construct spread-out vessel plots that portrayed the spatial location of the detected tissues and their extent was expressed as percentage of the endoluminal vessel wall surface. Results: Twelve TCFA were detected at baseline in the scaffolded segments and all were covered at follow-up. On the other hand most of the TCFA identified in native segments (6 out of 10) did not change their phenotype at follow-up. The amount of the superficial lipid core remained unchanged at follow-up in the spread-out vessel plots in both the scaffolded (4.90AE10.12% at baseline vs. 4.18AE10.84%, at follow-up, P¼0.388) and native segments (28.47AE20.87% at baseline vs. 28.12AE22.00%, at follow-up, P¼0.767). There was no difference in the thickness of the neointima developed over TCFA and calcific spots in scaffolded segments at follow-up (mean thickness over TCFA: 223AE83mm vs. 213AE88mm over calcific spots, P¼0.687).
Conclusions: Our results demonstrate that the neointimal tissue developed after Absorb BVS implantation shields equally both lipid and calcific tissues. Thus, the Absorb BVS could be considered as a potential useful device for the invasive recapping of high risk plaques.
TCT-71
The Background: The morphological assessment of neointimal tissue using optical coherence tomography (OCT) is highly significant to clarify the pathophysiology of in-stent restenosis (ISR) lesions. These OCT findings may be related to recurrence of ISR. The aim of this study was to define the impact of OCT findings on recurrence of ISR after various types of percutaneous coronary intervention (PCI) including plain 
